Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients

Second-generation tyrosine kinase inhibitors (2G-TKIs) are effective at inducing complete cytogenetic responses (CCyRs) in approximately half of chronic myeloid leukemia patients treated while still in the chronic phase and after failing imatinib. It is less clear whether these responses are durable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Milojkovic, Dragana, Apperley, Jane F., Gerrard, Gareth, Ibrahim, Amr R., Szydlo, Richard, Bua, Marco, Reid, Alistair, Rezvani, Katayoun, Foroni, Letizia, Goldman, John, Marin, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5162552/
https://ncbi.nlm.nih.gov/pubmed/22174159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-383000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados